SecBot SecBot
Insider Cluster (3 insiders) ·Filed Mar 25, 2026

NUVL

Nuvalent, Inc.
BEARISH
Impact 7/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $1.7M total
Actionable Insight ▼ Bearish

Coordinated selling by multiple C-suite executives, especially the CFO, signals potential lack of confidence in near-term prospects. Traders should monitor upcoming earnings, pipeline updates, or clinical trial data for downward revisions or delays that may not yet be public.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$98.00
T+0 close · Mar 24, 2026 · via day close
Latest settled
+25.94%
T+60 · $123.43
Vs SPY
+12.49%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 25 $98.00entry
  2. T+1 · 8mo ago +0.06%α +1.83% · $98.06
  3. T+5 · 8mo ago +7.80%α +8.04% · $105.64
  4. T+20 · 7mo ago +10.22%α +2.36% · $108.02
  5. T+60 · 5mo ago +25.94%α +12.49% · $123.43
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three C-suite executives at Nuvalent sold a combined $1.71M in shares over a 7-day period, including CFO Alexandra Balcom who sold $1.37M, the largest individual transaction. These were open-market sales, not tax-related or non-cash events, and represent a coordinated exit by senior insiders.

Key Financial Metrics

Direction
selling
Total Value
$1.7M
Insiders
3

Key Facts

  • CFO Alexandra Balcom sold 13,700 shares for $1.37M at $100.16 per share on March 25, 2026
  • Chief Development Officer Darlene Noci sold 2,532 shares for $246,693 at $97.43 on March 30, 2026
  • Chief Legal Officer Deborah Miller sold 940 shares for $91,650 at $97.50 on March 26, 2026
  • Total open-market sales: $1.71M across three C-suite executives in seven days
  • Non-cash derivative exercises also occurred but are not economically significant

Financial Impact

$1.71M in insider selling by C-suite executives, representing 0.021% of Nuvalent's $8.1B market cap

insider sentimentshareholder confidencepotential dilution risk

Risk Factors

  • Insider selling may precede negative news such as clinical trial setbacks or funding challenges
  • Perception of weakening leadership confidence could pressure stock despite small absolute size of sales

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NUVL-1775075501840

US Market Status

Market Closed · Opens Wed (11h 50m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 1, 2026